Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Models, Genetic | 39 | 2024 | 3449 | 5.220 |
Why?
|
Genetic Association Studies | 27 | 2023 | 2741 | 4.230 |
Why?
|
Genome-Wide Association Study | 59 | 2024 | 12807 | 3.830 |
Why?
|
Polymorphism, Single Nucleotide | 69 | 2024 | 16047 | 2.610 |
Why?
|
Software | 14 | 2023 | 4462 | 1.800 |
Why?
|
Quantitative Trait Loci | 12 | 2023 | 2140 | 1.770 |
Why?
|
Data Interpretation, Statistical | 22 | 2019 | 2686 | 1.770 |
Why?
|
Genetic Variation | 19 | 2023 | 6610 | 1.660 |
Why?
|
Models, Statistical | 25 | 2020 | 5089 | 1.540 |
Why?
|
Genome, Human | 12 | 2024 | 4448 | 1.520 |
Why?
|
Biometry | 14 | 2011 | 571 | 1.520 |
Why?
|
Sequence Analysis, DNA | 11 | 2022 | 4772 | 1.450 |
Why?
|
Likelihood Functions | 11 | 2018 | 993 | 1.380 |
Why?
|
Phenotype | 31 | 2024 | 16721 | 1.320 |
Why?
|
Lung Neoplasms | 36 | 2024 | 13451 | 1.290 |
Why?
|
Algorithms | 21 | 2022 | 14071 | 1.290 |
Why?
|
Computer Simulation | 38 | 2024 | 6255 | 1.240 |
Why?
|
DNA Methylation | 25 | 2021 | 4424 | 1.200 |
Why?
|
Linear Models | 23 | 2020 | 5876 | 1.140 |
Why?
|
Genetic Markers | 6 | 2016 | 2601 | 1.040 |
Why?
|
Genetic Predisposition to Disease | 37 | 2024 | 18071 | 1.030 |
Why?
|
Welding | 9 | 2017 | 89 | 1.020 |
Why?
|
Epigenomics | 5 | 2020 | 959 | 1.010 |
Why?
|
Genetics, Population | 8 | 2024 | 943 | 0.960 |
Why?
|
Genome | 7 | 2022 | 1753 | 0.900 |
Why?
|
Nasopharyngeal Neoplasms | 2 | 2024 | 296 | 0.850 |
Why?
|
Computational Biology | 8 | 2020 | 3559 | 0.770 |
Why?
|
Lipids | 5 | 2023 | 3315 | 0.760 |
Why?
|
Biological Specimen Banks | 4 | 2024 | 786 | 0.750 |
Why?
|
Case-Control Studies | 31 | 2024 | 22223 | 0.690 |
Why?
|
Smoking | 19 | 2021 | 9081 | 0.670 |
Why?
|
Epstein-Barr Virus Infections | 2 | 2024 | 617 | 0.660 |
Why?
|
Arsenic | 5 | 2024 | 356 | 0.650 |
Why?
|
CpG Islands | 9 | 2020 | 1207 | 0.640 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 18 | 2024 | 5389 | 0.640 |
Why?
|
Principal Component Analysis | 6 | 2016 | 951 | 0.630 |
Why?
|
Multifactorial Inheritance | 2 | 2024 | 1425 | 0.630 |
Why?
|
Occupational Exposure | 12 | 2017 | 1805 | 0.630 |
Why?
|
Humans | 224 | 2024 | 765968 | 0.610 |
Why?
|
Gene Expression Profiling | 11 | 2020 | 9525 | 0.570 |
Why?
|
Pedigree | 4 | 2021 | 4526 | 0.570 |
Why?
|
Quantitative Trait, Heritable | 3 | 2016 | 541 | 0.540 |
Why?
|
Sample Size | 6 | 2021 | 845 | 0.520 |
Why?
|
Particulate Matter | 12 | 2021 | 2624 | 0.520 |
Why?
|
High-Throughput Nucleotide Sequencing | 3 | 2022 | 3655 | 0.520 |
Why?
|
Family | 4 | 2017 | 3209 | 0.510 |
Why?
|
Epigenesis, Genetic | 15 | 2020 | 3819 | 0.500 |
Why?
|
Survival Analysis | 7 | 2018 | 10070 | 0.490 |
Why?
|
Regression Analysis | 10 | 2022 | 6322 | 0.480 |
Why?
|
Molecular Sequence Annotation | 3 | 2023 | 523 | 0.480 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 747 | 0.480 |
Why?
|
Statistics as Topic | 3 | 2018 | 2352 | 0.460 |
Why?
|
Rare Diseases | 3 | 2018 | 635 | 0.450 |
Why?
|
Neuroendocrine Tumors | 6 | 2017 | 654 | 0.450 |
Why?
|
Genotype | 21 | 2024 | 13024 | 0.440 |
Why?
|
Longitudinal Studies | 20 | 2020 | 14751 | 0.440 |
Why?
|
Oxyhemoglobins | 3 | 2019 | 213 | 0.430 |
Why?
|
Disease | 1 | 2019 | 676 | 0.430 |
Why?
|
Logistic Models | 14 | 2018 | 13266 | 0.430 |
Why?
|
Causality | 4 | 2021 | 1248 | 0.420 |
Why?
|
Arsenic Poisoning | 2 | 2015 | 55 | 0.410 |
Why?
|
Population | 1 | 2013 | 140 | 0.400 |
Why?
|
Environmental Exposure | 7 | 2021 | 4544 | 0.390 |
Why?
|
Mandibulofacial Dysostosis | 1 | 2011 | 37 | 0.390 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 4 | 2022 | 326 | 0.390 |
Why?
|
Genetic Pleiotropy | 1 | 2013 | 182 | 0.380 |
Why?
|
Craniofacial Dysostosis | 1 | 2011 | 74 | 0.380 |
Why?
|
Linkage Disequilibrium | 5 | 2023 | 1997 | 0.380 |
Why?
|
Micrognathism | 1 | 2011 | 63 | 0.370 |
Why?
|
Hypersensitivity, Immediate | 3 | 2019 | 346 | 0.370 |
Why?
|
Proportional Hazards Models | 10 | 2019 | 12509 | 0.370 |
Why?
|
Bayes Theorem | 7 | 2024 | 2354 | 0.370 |
Why?
|
Metals | 4 | 2016 | 710 | 0.360 |
Why?
|
Asthma | 11 | 2019 | 6270 | 0.360 |
Why?
|
Population Groups | 1 | 2012 | 209 | 0.360 |
Why?
|
Coronavirus Infections | 4 | 2020 | 3100 | 0.360 |
Why?
|
Limb Deformities, Congenital | 1 | 2011 | 136 | 0.350 |
Why?
|
Sequence Analysis | 1 | 2011 | 239 | 0.350 |
Why?
|
Sleep Apnea, Obstructive | 6 | 2022 | 1896 | 0.350 |
Why?
|
Pneumonia, Viral | 4 | 2020 | 3223 | 0.350 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2012 | 360 | 0.350 |
Why?
|
Poisson Distribution | 2 | 2011 | 508 | 0.350 |
Why?
|
Genetic Diseases, Inborn | 2 | 2013 | 605 | 0.340 |
Why?
|
Air Pollutants, Occupational | 6 | 2017 | 406 | 0.330 |
Why?
|
Acute Kidney Injury | 1 | 2022 | 1946 | 0.330 |
Why?
|
Adiponectin | 1 | 2015 | 1119 | 0.320 |
Why?
|
Knowledge Bases | 1 | 2009 | 96 | 0.320 |
Why?
|
Air Pollutants | 7 | 2021 | 2923 | 0.320 |
Why?
|
Epidemiologic Research Design | 2 | 2012 | 368 | 0.310 |
Why?
|
Vestibular Diseases | 1 | 2011 | 230 | 0.310 |
Why?
|
Genetic Linkage | 7 | 2019 | 2341 | 0.300 |
Why?
|
Meta-Analysis as Topic | 1 | 2013 | 1370 | 0.300 |
Why?
|
Autistic Disorder | 1 | 2017 | 1239 | 0.290 |
Why?
|
Chromosome Mapping | 7 | 2019 | 4618 | 0.290 |
Why?
|
Hematologic Diseases | 1 | 2011 | 500 | 0.290 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2022 | 2310 | 0.290 |
Why?
|
Oligonucleotide Array Sequence Analysis | 8 | 2016 | 3797 | 0.290 |
Why?
|
Male | 100 | 2024 | 363698 | 0.280 |
Why?
|
Genomics | 7 | 2023 | 5929 | 0.280 |
Why?
|
Protein Interaction Mapping | 1 | 2011 | 619 | 0.280 |
Why?
|
Artificial Intelligence | 3 | 2012 | 2659 | 0.270 |
Why?
|
Statistics, Nonparametric | 5 | 2011 | 2844 | 0.270 |
Why?
|
Air Pollution | 6 | 2021 | 2380 | 0.270 |
Why?
|
Gene Frequency | 10 | 2021 | 3624 | 0.270 |
Why?
|
Angiopoietin-2 | 2 | 2018 | 187 | 0.260 |
Why?
|
Heart | 5 | 2017 | 4414 | 0.260 |
Why?
|
Spectrometry, Mass, Electrospray Ionization | 1 | 2007 | 269 | 0.260 |
Why?
|
Heart Rate | 6 | 2017 | 4204 | 0.260 |
Why?
|
Herpesvirus 4, Human | 2 | 2024 | 1078 | 0.260 |
Why?
|
Databases, Genetic | 2 | 2019 | 1751 | 0.250 |
Why?
|
Ovulation | 1 | 2006 | 178 | 0.250 |
Why?
|
Manganese | 4 | 2017 | 395 | 0.250 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2007 | 507 | 0.250 |
Why?
|
Blood Chemical Analysis | 1 | 2007 | 433 | 0.250 |
Why?
|
Pandemics | 7 | 2022 | 8703 | 0.250 |
Why?
|
Lung | 7 | 2023 | 10033 | 0.240 |
Why?
|
Acid Ceramidase | 3 | 2013 | 21 | 0.240 |
Why?
|
Female | 101 | 2024 | 396112 | 0.240 |
Why?
|
Proteomics | 4 | 2023 | 3910 | 0.240 |
Why?
|
Alcoholism | 1 | 2015 | 1975 | 0.230 |
Why?
|
Mercury | 2 | 2017 | 291 | 0.230 |
Why?
|
Abnormalities, Multiple | 1 | 2011 | 1424 | 0.230 |
Why?
|
Middle Aged | 73 | 2024 | 223009 | 0.220 |
Why?
|
Specimen Handling | 2 | 2010 | 704 | 0.220 |
Why?
|
Genes | 3 | 2013 | 1825 | 0.220 |
Why?
|
Neoplasm Proteins | 3 | 2015 | 3596 | 0.210 |
Why?
|
Autonomic Nervous System | 3 | 2017 | 706 | 0.210 |
Why?
|
Cohort Studies | 21 | 2022 | 41649 | 0.210 |
Why?
|
Space-Time Clustering | 1 | 2003 | 45 | 0.210 |
Why?
|
Gene Regulatory Networks | 5 | 2022 | 1748 | 0.210 |
Why?
|
Prostatic Neoplasms | 6 | 2014 | 11083 | 0.210 |
Why?
|
DNA Mutational Analysis | 1 | 2011 | 4108 | 0.210 |
Why?
|
Patient Dropouts | 1 | 2005 | 410 | 0.210 |
Why?
|
Veterans | 3 | 2021 | 2664 | 0.200 |
Why?
|
Genetic Loci | 4 | 2020 | 2631 | 0.200 |
Why?
|
Sleep Apnea Syndromes | 3 | 2021 | 969 | 0.200 |
Why?
|
Trophoblasts | 1 | 2024 | 223 | 0.200 |
Why?
|
Ferrochelatase | 2 | 2020 | 47 | 0.200 |
Why?
|
Fetal Blood | 6 | 2019 | 1369 | 0.200 |
Why?
|
Haplotypes | 7 | 2021 | 2728 | 0.200 |
Why?
|
Placenta | 2 | 2024 | 1728 | 0.200 |
Why?
|
Blood Proteins | 1 | 2008 | 1188 | 0.200 |
Why?
|
Research | 2 | 2021 | 1975 | 0.200 |
Why?
|
Bangladesh | 6 | 2018 | 745 | 0.190 |
Why?
|
Menopause | 3 | 2007 | 1659 | 0.190 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 2 | 2018 | 1140 | 0.190 |
Why?
|
Nails | 3 | 2014 | 298 | 0.190 |
Why?
|
Mass Spectrometry | 2 | 2012 | 2194 | 0.190 |
Why?
|
Alleles | 6 | 2024 | 6897 | 0.190 |
Why?
|
Leukocytes | 4 | 2019 | 2027 | 0.190 |
Why?
|
Sleep | 5 | 2019 | 4813 | 0.190 |
Why?
|
Lead | 2 | 2017 | 879 | 0.190 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 3 | 2024 | 1761 | 0.190 |
Why?
|
Epistasis, Genetic | 2 | 2015 | 353 | 0.180 |
Why?
|
Aging, Premature | 1 | 2021 | 44 | 0.180 |
Why?
|
Water Pollutants, Chemical | 3 | 2014 | 358 | 0.180 |
Why?
|
Microfilament Proteins | 2 | 2017 | 1130 | 0.180 |
Why?
|
Age of Onset | 1 | 2008 | 3344 | 0.180 |
Why?
|
Twin Studies as Topic | 2 | 2018 | 103 | 0.180 |
Why?
|
Radiotherapy Dosage | 1 | 2007 | 2865 | 0.180 |
Why?
|
Models, Biological | 6 | 2020 | 9443 | 0.170 |
Why?
|
Aged | 54 | 2024 | 171117 | 0.170 |
Why?
|
Radiation Injuries | 1 | 2007 | 1181 | 0.170 |
Why?
|
Reproducibility of Results | 8 | 2022 | 20124 | 0.170 |
Why?
|
Protoporphyria, Erythropoietic | 1 | 2020 | 54 | 0.170 |
Why?
|
Maternal Exposure | 2 | 2017 | 1095 | 0.170 |
Why?
|
Heme | 1 | 2022 | 316 | 0.170 |
Why?
|
Esophageal Neoplasms | 4 | 2011 | 1661 | 0.160 |
Why?
|
Birth Weight | 3 | 2016 | 2121 | 0.160 |
Why?
|
Chromosomes, Human, Pair 8 | 2 | 2019 | 451 | 0.160 |
Why?
|
Interleukin-18 Receptor alpha Subunit | 1 | 2019 | 18 | 0.160 |
Why?
|
5-Methylcytosine | 1 | 2020 | 148 | 0.160 |
Why?
|
Environmental Illness | 1 | 2019 | 33 | 0.160 |
Why?
|
Metabolic Networks and Pathways | 2 | 2022 | 798 | 0.160 |
Why?
|
Mortality | 2 | 2021 | 2904 | 0.160 |
Why?
|
Oncogenes | 3 | 2021 | 1235 | 0.160 |
Why?
|
Heart Diseases | 6 | 2014 | 2821 | 0.160 |
Why?
|
Hexokinase | 1 | 2019 | 125 | 0.150 |
Why?
|
Biological Transport | 1 | 2023 | 2081 | 0.150 |
Why?
|
Genes, Tumor Suppressor | 3 | 2019 | 1061 | 0.150 |
Why?
|
Body Size | 1 | 2021 | 459 | 0.150 |
Why?
|
Adult | 52 | 2022 | 223044 | 0.150 |
Why?
|
Child Development Disorders, Pervasive | 2 | 2013 | 597 | 0.150 |
Why?
|
Lymphocyte Count | 1 | 2020 | 790 | 0.150 |
Why?
|
Humidity | 1 | 2019 | 206 | 0.150 |
Why?
|
Patient Compliance | 1 | 2008 | 2692 | 0.140 |
Why?
|
Adenocarcinoma | 5 | 2018 | 6364 | 0.140 |
Why?
|
Chromosomes, Human, Pair 4 | 1 | 2019 | 378 | 0.140 |
Why?
|
DNA-Binding Proteins | 5 | 2022 | 9601 | 0.140 |
Why?
|
Prognosis | 9 | 2021 | 29922 | 0.140 |
Why?
|
Prenatal Exposure Delayed Effects | 4 | 2017 | 2531 | 0.140 |
Why?
|
Europe | 4 | 2020 | 3423 | 0.140 |
Why?
|
Asymptomatic Diseases | 1 | 2020 | 586 | 0.140 |
Why?
|
Workflow | 1 | 2022 | 862 | 0.140 |
Why?
|
Michigan | 4 | 2012 | 328 | 0.140 |
Why?
|
Receptors, Somatostatin | 2 | 2016 | 138 | 0.140 |
Why?
|
Gene Dosage | 2 | 2011 | 1216 | 0.140 |
Why?
|
Menarche | 2 | 2018 | 532 | 0.140 |
Why?
|
Environmental Monitoring | 5 | 2019 | 1470 | 0.130 |
Why?
|
Ohio | 2 | 2016 | 320 | 0.130 |
Why?
|
Diabetes Mellitus, Type 2 | 5 | 2023 | 12240 | 0.130 |
Why?
|
GTPase-Activating Proteins | 1 | 2019 | 465 | 0.130 |
Why?
|
Educational Status | 2 | 2023 | 2513 | 0.130 |
Why?
|
Probability | 1 | 2022 | 2475 | 0.130 |
Why?
|
Sulfates | 2 | 2014 | 376 | 0.130 |
Why?
|
Neck | 1 | 2021 | 733 | 0.130 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2003 | 1140 | 0.130 |
Why?
|
Leukocyte Count | 1 | 2020 | 1602 | 0.130 |
Why?
|
Central America | 1 | 2016 | 69 | 0.130 |
Why?
|
Dust | 3 | 2014 | 489 | 0.130 |
Why?
|
Phylogeography | 1 | 2016 | 71 | 0.130 |
Why?
|
Fasting | 1 | 2022 | 1606 | 0.130 |
Why?
|
Bronchial Neoplasms | 1 | 2016 | 109 | 0.130 |
Why?
|
South America | 1 | 2016 | 179 | 0.130 |
Why?
|
Platelet Count | 2 | 2017 | 782 | 0.130 |
Why?
|
Mutation | 7 | 2024 | 30198 | 0.130 |
Why?
|
Renal Insufficiency | 1 | 2021 | 804 | 0.120 |
Why?
|
United States | 13 | 2022 | 72903 | 0.120 |
Why?
|
Genome, Viral | 1 | 2019 | 670 | 0.120 |
Why?
|
Stress, Physiological | 3 | 2024 | 1402 | 0.120 |
Why?
|
Fibrinogen | 1 | 2019 | 895 | 0.120 |
Why?
|
Immunoglobulin E | 2 | 2019 | 1481 | 0.120 |
Why?
|
Histone Demethylases | 1 | 2018 | 328 | 0.120 |
Why?
|
Odds Ratio | 4 | 2018 | 9649 | 0.120 |
Why?
|
Bone Density | 3 | 2007 | 3491 | 0.120 |
Why?
|
Maternal-Fetal Exchange | 1 | 2017 | 453 | 0.120 |
Why?
|
Risk Assessment | 8 | 2024 | 24282 | 0.120 |
Why?
|
Skin Diseases | 2 | 2014 | 1088 | 0.120 |
Why?
|
Sleep, REM | 1 | 2018 | 588 | 0.120 |
Why?
|
Vascular Endothelial Growth Factor A | 4 | 2014 | 3513 | 0.120 |
Why?
|
Cholesterol, LDL | 2 | 2022 | 2393 | 0.120 |
Why?
|
Randomized Controlled Trials as Topic | 4 | 2008 | 10383 | 0.120 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2018 | 618 | 0.110 |
Why?
|
Coronary Artery Disease | 4 | 2023 | 6544 | 0.110 |
Why?
|
Risk Factors | 21 | 2024 | 74840 | 0.110 |
Why?
|
Sensitivity and Specificity | 5 | 2015 | 14652 | 0.110 |
Why?
|
Heart Septal Defects, Ventricular | 1 | 2017 | 477 | 0.110 |
Why?
|
Carbon | 2 | 2014 | 677 | 0.110 |
Why?
|
False Positive Reactions | 2 | 2017 | 955 | 0.110 |
Why?
|
Intestinal Neoplasms | 1 | 2016 | 313 | 0.110 |
Why?
|
Asbestos | 1 | 2015 | 250 | 0.110 |
Why?
|
Time Factors | 12 | 2020 | 40065 | 0.110 |
Why?
|
Communicable Disease Control | 1 | 2020 | 856 | 0.110 |
Why?
|
Extracellular Matrix Proteins | 2 | 2019 | 833 | 0.110 |
Why?
|
Health Education | 2 | 2014 | 1060 | 0.100 |
Why?
|
Receptor, Notch2 | 1 | 2013 | 90 | 0.100 |
Why?
|
Analysis of Variance | 4 | 2017 | 6203 | 0.100 |
Why?
|
Nod2 Signaling Adaptor Protein | 1 | 2013 | 85 | 0.100 |
Why?
|
Mutagens | 1 | 2014 | 179 | 0.100 |
Why?
|
Inflammation | 3 | 2020 | 10850 | 0.100 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2015 | 416 | 0.100 |
Why?
|
Clinical Trials as Topic | 1 | 2009 | 8041 | 0.100 |
Why?
|
Cognition | 4 | 2021 | 7049 | 0.100 |
Why?
|
Single-Cell Analysis | 1 | 2024 | 2535 | 0.100 |
Why?
|
Research Design | 3 | 2019 | 6209 | 0.100 |
Why?
|
Forced Expiratory Volume | 5 | 2020 | 1828 | 0.100 |
Why?
|
Angiopoietins | 1 | 2012 | 86 | 0.100 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 1 | 2014 | 416 | 0.100 |
Why?
|
C-Reactive Protein | 3 | 2019 | 3850 | 0.100 |
Why?
|
Temperature | 1 | 2019 | 2226 | 0.100 |
Why?
|
Plaque, Atherosclerotic | 1 | 2023 | 1529 | 0.100 |
Why?
|
Ribosomes | 1 | 2015 | 493 | 0.100 |
Why?
|
Viral Proteins | 1 | 2019 | 1797 | 0.100 |
Why?
|
Gene Expression Regulation | 2 | 2021 | 11888 | 0.100 |
Why?
|
Longevity | 1 | 2019 | 1087 | 0.100 |
Why?
|
Signal Transduction | 7 | 2021 | 23601 | 0.100 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2015 | 657 | 0.100 |
Why?
|
Chromosomes, Human, Pair 10 | 1 | 2012 | 274 | 0.100 |
Why?
|
Appendicitis | 1 | 2018 | 679 | 0.100 |
Why?
|
Selection, Genetic | 1 | 2016 | 878 | 0.090 |
Why?
|
Quality Control | 2 | 2021 | 837 | 0.090 |
Why?
|
Interleukin-12 Subunit p35 | 1 | 2011 | 22 | 0.090 |
Why?
|
Occupations | 1 | 2014 | 516 | 0.090 |
Why?
|
Nitrosamines | 1 | 2011 | 85 | 0.090 |
Why?
|
Heredity | 1 | 2011 | 149 | 0.090 |
Why?
|
Adiposity | 1 | 2021 | 1890 | 0.090 |
Why?
|
Environmental Pollutants | 2 | 2017 | 1290 | 0.090 |
Why?
|
Food Hypersensitivity | 1 | 2019 | 737 | 0.090 |
Why?
|
Angiogenic Proteins | 1 | 2011 | 101 | 0.090 |
Why?
|
Inhalation Exposure | 1 | 2014 | 432 | 0.090 |
Why?
|
Aged, 80 and over | 19 | 2022 | 59489 | 0.090 |
Why?
|
Risk | 3 | 2013 | 9591 | 0.090 |
Why?
|
Self Care | 2 | 2014 | 800 | 0.090 |
Why?
|
Heterozygote | 2 | 2021 | 2794 | 0.090 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2015 | 689 | 0.090 |
Why?
|
Rural Population | 1 | 2021 | 2317 | 0.090 |
Why?
|
Oxidoreductases Acting on CH-CH Group Donors | 1 | 2011 | 173 | 0.090 |
Why?
|
Oxygen Consumption | 1 | 2016 | 1870 | 0.090 |
Why?
|
Disease Management | 3 | 2008 | 2535 | 0.090 |
Why?
|
Atherosclerosis | 2 | 2023 | 3424 | 0.090 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2020 | 2268 | 0.080 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2014 | 1240 | 0.080 |
Why?
|
China | 3 | 2020 | 2385 | 0.080 |
Why?
|
Estrogen Receptor beta | 1 | 2010 | 171 | 0.080 |
Why?
|
Tumor Suppressor Proteins | 1 | 2019 | 2796 | 0.080 |
Why?
|
Vital Capacity | 3 | 2020 | 995 | 0.080 |
Why?
|
Elafin | 1 | 2009 | 29 | 0.080 |
Why?
|
Occupational Diseases | 2 | 2014 | 1456 | 0.080 |
Why?
|
Particle Size | 4 | 2016 | 1631 | 0.080 |
Why?
|
Child | 16 | 2020 | 80564 | 0.080 |
Why?
|
Discriminant Analysis | 1 | 2009 | 222 | 0.080 |
Why?
|
Hospitals | 1 | 2022 | 3888 | 0.080 |
Why?
|
Epithelial Cells | 1 | 2020 | 3681 | 0.080 |
Why?
|
Lung Diseases | 1 | 2018 | 1940 | 0.070 |
Why?
|
Leukocyte Elastase | 1 | 2009 | 113 | 0.070 |
Why?
|
Calcium-Binding Proteins | 1 | 2013 | 1077 | 0.070 |
Why?
|
Fetal Growth Retardation | 1 | 2012 | 591 | 0.070 |
Why?
|
Receptors, Cell Surface | 1 | 2017 | 2817 | 0.070 |
Why?
|
Physicians, Primary Care | 1 | 2014 | 622 | 0.070 |
Why?
|
Mutation, Missense | 1 | 2017 | 2589 | 0.070 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 3 | 2020 | 3247 | 0.070 |
Why?
|
Telomere | 1 | 2014 | 943 | 0.070 |
Why?
|
Neutrophils | 1 | 2020 | 3776 | 0.070 |
Why?
|
Follicle Stimulating Hormone | 2 | 2007 | 731 | 0.070 |
Why?
|
Stress, Psychological | 2 | 2018 | 4533 | 0.070 |
Why?
|
Nuclear Proteins | 3 | 2023 | 5783 | 0.070 |
Why?
|
NF-kappa B | 2 | 2014 | 2485 | 0.070 |
Why?
|
Aging | 4 | 2021 | 8731 | 0.070 |
Why?
|
Polysomnography | 4 | 2022 | 1859 | 0.070 |
Why?
|
Menstrual Cycle | 3 | 2007 | 540 | 0.070 |
Why?
|
Sex Factors | 1 | 2021 | 10603 | 0.070 |
Why?
|
Pregnancy | 9 | 2024 | 30260 | 0.070 |
Why?
|
Repressor Proteins | 1 | 2017 | 2968 | 0.070 |
Why?
|
Databases, Protein | 1 | 2009 | 391 | 0.070 |
Why?
|
Parotid Gland | 1 | 2007 | 177 | 0.070 |
Why?
|
Body Mass Index | 5 | 2017 | 13039 | 0.070 |
Why?
|
Chromatography, Liquid | 1 | 2010 | 990 | 0.070 |
Why?
|
Parity | 1 | 2010 | 931 | 0.070 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2014 | 1936 | 0.070 |
Why?
|
Cytoskeletal Proteins | 1 | 2011 | 1325 | 0.060 |
Why?
|
Gene Expression Regulation, Neoplastic | 5 | 2018 | 8611 | 0.060 |
Why?
|
Gastroesophageal Reflux | 2 | 2011 | 833 | 0.060 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2007 | 869 | 0.060 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2011 | 1151 | 0.060 |
Why?
|
Acceleration | 2 | 2017 | 187 | 0.060 |
Why?
|
Adrenal Cortex Hormones | 2 | 2012 | 1880 | 0.060 |
Why?
|
Germ-Line Mutation | 1 | 2014 | 1884 | 0.060 |
Why?
|
Child Development | 1 | 2017 | 2327 | 0.060 |
Why?
|
Face | 1 | 2011 | 1028 | 0.060 |
Why?
|
Positron-Emission Tomography | 1 | 2022 | 6547 | 0.060 |
Why?
|
Prospective Studies | 12 | 2023 | 54802 | 0.060 |
Why?
|
Patient Satisfaction | 2 | 2008 | 3475 | 0.060 |
Why?
|
Phosphatidylethanolamine N-Methyltransferase | 2 | 2018 | 19 | 0.060 |
Why?
|
Matrix Metalloproteinase 1 | 1 | 2005 | 147 | 0.060 |
Why?
|
Mexico | 2 | 2018 | 777 | 0.060 |
Why?
|
Adolescent | 9 | 2022 | 88835 | 0.060 |
Why?
|
Promoter Regions, Genetic | 2 | 2014 | 5786 | 0.060 |
Why?
|
Matrix Metalloproteinase 3 | 1 | 2005 | 139 | 0.060 |
Why?
|
Endoplasmic Reticulum | 1 | 2011 | 1132 | 0.060 |
Why?
|
Apoptosis | 3 | 2010 | 9514 | 0.060 |
Why?
|
Transcription Factors | 3 | 2023 | 12131 | 0.060 |
Why?
|
Triglycerides | 1 | 2012 | 2441 | 0.060 |
Why?
|
Retrospective Studies | 7 | 2023 | 81514 | 0.060 |
Why?
|
Young Adult | 11 | 2022 | 59889 | 0.060 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 2 | 2 | 2019 | 220 | 0.060 |
Why?
|
Polymorphism, Genetic | 3 | 2014 | 4247 | 0.060 |
Why?
|
Mendelian Randomization Analysis | 2 | 2022 | 1044 | 0.060 |
Why?
|
Sepsis | 1 | 2018 | 2606 | 0.060 |
Why?
|
Feedback | 1 | 2008 | 796 | 0.060 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2013 | 2056 | 0.060 |
Why?
|
Choice Behavior | 2 | 2008 | 844 | 0.060 |
Why?
|
Proto-Oncogene Proteins | 1 | 2016 | 4520 | 0.060 |
Why?
|
Pharmacokinetics | 1 | 2004 | 86 | 0.060 |
Why?
|
Tandem Mass Spectrometry | 1 | 2010 | 1192 | 0.060 |
Why?
|
Up-Regulation | 2 | 2024 | 4137 | 0.060 |
Why?
|
Metalloendopeptidases | 1 | 2005 | 386 | 0.060 |
Why?
|
Health Promotion | 2 | 2007 | 2208 | 0.050 |
Why?
|
Luteinizing Hormone | 1 | 2006 | 826 | 0.050 |
Why?
|
Epidemiologic Methods | 2 | 2009 | 1326 | 0.050 |
Why?
|
Wounds and Injuries | 1 | 2016 | 2511 | 0.050 |
Why?
|
Multivariate Analysis | 3 | 2016 | 12056 | 0.050 |
Why?
|
Massachusetts | 5 | 2014 | 8875 | 0.050 |
Why?
|
Information Storage and Retrieval | 1 | 2009 | 834 | 0.050 |
Why?
|
Folic Acid | 1 | 2010 | 1338 | 0.050 |
Why?
|
Xerophthalmia | 1 | 2003 | 12 | 0.050 |
Why?
|
HIV Protease Inhibitors | 1 | 2005 | 430 | 0.050 |
Why?
|
Respiratory Function Tests | 2 | 2020 | 1693 | 0.050 |
Why?
|
Saliva | 1 | 2007 | 851 | 0.050 |
Why?
|
Common Cold | 1 | 2003 | 63 | 0.050 |
Why?
|
Indonesia | 1 | 2003 | 131 | 0.050 |
Why?
|
Lipid Metabolism | 1 | 2011 | 1892 | 0.050 |
Why?
|
CD4 Lymphocyte Count | 2 | 2005 | 2587 | 0.050 |
Why?
|
Long Interspersed Nucleotide Elements | 2 | 2014 | 332 | 0.050 |
Why?
|
Area Under Curve | 1 | 2006 | 1638 | 0.050 |
Why?
|
Down Syndrome | 1 | 2010 | 915 | 0.050 |
Why?
|
Epilepsy, Complex Partial | 1 | 2002 | 59 | 0.050 |
Why?
|
Interleukin-8 | 2 | 2016 | 700 | 0.050 |
Why?
|
Menstruation Disturbances | 1 | 2003 | 139 | 0.050 |
Why?
|
Ozone | 1 | 2005 | 499 | 0.050 |
Why?
|
Prevalence | 5 | 2024 | 15842 | 0.050 |
Why?
|
Hematopoietic Stem Cells | 1 | 2014 | 3401 | 0.050 |
Why?
|
Blood Pressure | 1 | 2017 | 8532 | 0.050 |
Why?
|
Caveolin 1 | 1 | 2022 | 255 | 0.050 |
Why?
|
Research Subjects | 1 | 2003 | 247 | 0.040 |
Why?
|
Metals, Heavy | 2 | 2014 | 151 | 0.040 |
Why?
|
Education, Medical, Continuing | 1 | 2006 | 830 | 0.040 |
Why?
|
Membrane Proteins | 3 | 2014 | 7851 | 0.040 |
Why?
|
Radiotherapy | 1 | 2007 | 1494 | 0.040 |
Why?
|
Follow-Up Studies | 5 | 2019 | 39193 | 0.040 |
Why?
|
Maximal Midexpiratory Flow Rate | 1 | 2020 | 75 | 0.040 |
Why?
|
Cytochrome P-450 CYP2D6 | 1 | 2021 | 108 | 0.040 |
Why?
|
Osteoporosis, Postmenopausal | 1 | 2004 | 399 | 0.040 |
Why?
|
Crohn Disease | 1 | 2013 | 2283 | 0.040 |
Why?
|
Calcium | 2 | 2011 | 5767 | 0.040 |
Why?
|
Population Density | 1 | 2021 | 193 | 0.040 |
Why?
|
Chromosomes | 1 | 2023 | 578 | 0.040 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2023 | 385 | 0.040 |
Why?
|
Homeostasis | 1 | 2011 | 3336 | 0.040 |
Why?
|
Genetic Testing | 1 | 2013 | 3595 | 0.040 |
Why?
|
INDEL Mutation | 1 | 2021 | 268 | 0.040 |
Why?
|
Breast Neoplasms | 6 | 2019 | 21056 | 0.040 |
Why?
|
Nasal Mucosa | 1 | 2003 | 416 | 0.040 |
Why?
|
Pyridines | 1 | 2011 | 2888 | 0.040 |
Why?
|
Interleukin-10 | 2 | 2016 | 1183 | 0.040 |
Why?
|
Aneuploidy | 1 | 2023 | 578 | 0.040 |
Why?
|
Proteins | 1 | 2014 | 5995 | 0.040 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2015 | 4044 | 0.040 |
Why?
|
Stochastic Processes | 1 | 2020 | 358 | 0.040 |
Why?
|
Fetal Development | 2 | 2016 | 777 | 0.040 |
Why?
|
Parents | 3 | 2014 | 3592 | 0.040 |
Why?
|
Chromosomes, Human | 2 | 2016 | 437 | 0.040 |
Why?
|
ABO Blood-Group System | 1 | 2021 | 380 | 0.040 |
Why?
|
Electrocardiography | 3 | 2017 | 6404 | 0.040 |
Why?
|
Disease Susceptibility | 2 | 2020 | 1789 | 0.040 |
Why?
|
Uncertainty | 1 | 2024 | 761 | 0.040 |
Why?
|
Gestational Age | 2 | 2019 | 3609 | 0.040 |
Why?
|
Respiratory Tract Infections | 2 | 2005 | 1008 | 0.040 |
Why?
|
Sulfur Dioxide | 1 | 2019 | 178 | 0.040 |
Why?
|
Minnesota | 2 | 2013 | 336 | 0.040 |
Why?
|
Pancreatic Neoplasms | 1 | 2016 | 5444 | 0.040 |
Why?
|
Calcinosis | 1 | 2007 | 1479 | 0.040 |
Why?
|
Placebos | 1 | 2003 | 1659 | 0.040 |
Why?
|
RNA-Binding Proteins | 2 | 2022 | 1874 | 0.040 |
Why?
|
History, 21st Century | 2 | 2014 | 1574 | 0.040 |
Why?
|
Incidence | 4 | 2020 | 21480 | 0.040 |
Why?
|
Nerve Tissue Proteins | 2 | 2022 | 4392 | 0.040 |
Why?
|
DNA, Neoplasm | 2 | 2015 | 1742 | 0.040 |
Why?
|
Neoplasm Staging | 4 | 2018 | 11206 | 0.040 |
Why?
|
Mothers | 2 | 2019 | 2210 | 0.040 |
Why?
|
Epilepsy | 2 | 2003 | 3320 | 0.040 |
Why?
|
Neuropsychological Tests | 1 | 2010 | 7123 | 0.040 |
Why?
|
Sterol Regulatory Element Binding Protein 1 | 1 | 2018 | 135 | 0.040 |
Why?
|
Proteome | 1 | 2007 | 1899 | 0.040 |
Why?
|
DNA Helicases | 1 | 2023 | 852 | 0.040 |
Why?
|
Cell Adhesion Molecules, Neuronal | 1 | 2019 | 262 | 0.040 |
Why?
|
Psychotropic Drugs | 1 | 2003 | 879 | 0.040 |
Why?
|
Severity of Illness Index | 4 | 2022 | 15880 | 0.040 |
Why?
|
HIV Seropositivity | 1 | 2003 | 961 | 0.040 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2012 | 2429 | 0.040 |
Why?
|
Aryldialkylphosphatase | 1 | 2017 | 64 | 0.030 |
Why?
|
Disease Progression | 5 | 2017 | 13632 | 0.030 |
Why?
|
Mutagenesis | 1 | 2021 | 1228 | 0.030 |
Why?
|
Chromium | 1 | 2017 | 132 | 0.030 |
Why?
|
Chromosome Aberrations | 1 | 2023 | 1774 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2024 | 2034 | 0.030 |
Why?
|
Oxygen | 2 | 2019 | 4241 | 0.030 |
Why?
|
Cell Cycle | 1 | 2024 | 2920 | 0.030 |
Why?
|
Health Status | 3 | 2020 | 4080 | 0.030 |
Why?
|
Receptors, Immunologic | 1 | 2022 | 1415 | 0.030 |
Why?
|
Obesity | 2 | 2011 | 13076 | 0.030 |
Why?
|
Glucose | 2 | 2022 | 4335 | 0.030 |
Why?
|
Nitrogen Dioxide | 1 | 2019 | 538 | 0.030 |
Why?
|
Child, Preschool | 5 | 2018 | 42500 | 0.030 |
Why?
|
Carbon Monoxide | 1 | 2019 | 560 | 0.030 |
Why?
|
Chromosomes, Human, Pair 16 | 1 | 2017 | 340 | 0.030 |
Why?
|
Skin Neoplasms | 1 | 2015 | 5849 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 3 | 2013 | 6499 | 0.030 |
Why?
|
Interleukin-1beta | 2 | 2014 | 1028 | 0.030 |
Why?
|
Liver | 1 | 2011 | 7562 | 0.030 |
Why?
|
Motor Skills | 1 | 2018 | 516 | 0.030 |
Why?
|
Chi-Square Distribution | 2 | 2013 | 3432 | 0.030 |
Why?
|
Gases | 1 | 2016 | 206 | 0.030 |
Why?
|
Multicenter Studies as Topic | 2 | 2014 | 1731 | 0.030 |
Why?
|
Uric Acid | 1 | 2021 | 809 | 0.030 |
Why?
|
Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2016 | 276 | 0.030 |
Why?
|
Endothelin-1 | 1 | 2016 | 295 | 0.030 |
Why?
|
Interleukin-6 | 2 | 2016 | 3222 | 0.030 |
Why?
|
Disease Transmission, Infectious | 1 | 2020 | 560 | 0.030 |
Why?
|
Work | 1 | 2015 | 195 | 0.030 |
Why?
|
Somatostatin | 1 | 2016 | 459 | 0.030 |
Why?
|
Disease-Free Survival | 2 | 2016 | 6832 | 0.030 |
Why?
|
Age Factors | 2 | 2008 | 18380 | 0.030 |
Why?
|
Gene Expression | 2 | 2017 | 7584 | 0.030 |
Why?
|
Labor Unions | 1 | 2014 | 50 | 0.030 |
Why?
|
Serine Endopeptidases | 1 | 2019 | 1024 | 0.030 |
Why?
|
Smad Proteins | 1 | 2014 | 157 | 0.030 |
Why?
|
Heart Defects, Congenital | 1 | 2010 | 4697 | 0.030 |
Why?
|
Alu Elements | 1 | 2014 | 115 | 0.030 |
Why?
|
Chromogranin A | 1 | 2013 | 49 | 0.030 |
Why?
|
Air | 1 | 2014 | 181 | 0.030 |
Why?
|
Diabetes Mellitus | 2 | 2009 | 5891 | 0.030 |
Why?
|
Sex Characteristics | 2 | 2018 | 2643 | 0.030 |
Why?
|
Head and Neck Neoplasms | 1 | 2007 | 2921 | 0.030 |
Why?
|
Iron | 1 | 2022 | 1816 | 0.030 |
Why?
|
Malaria | 1 | 2003 | 1246 | 0.030 |
Why?
|
Electrocardiography, Ambulatory | 1 | 2015 | 582 | 0.030 |
Why?
|
Program Evaluation | 2 | 2014 | 2499 | 0.030 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2014 | 306 | 0.030 |
Why?
|
Anticonvulsants | 1 | 2003 | 1921 | 0.030 |
Why?
|
ras Proteins | 1 | 2018 | 1053 | 0.030 |
Why?
|
Body Height | 1 | 2019 | 1562 | 0.030 |
Why?
|
Family Health | 1 | 2017 | 1253 | 0.020 |
Why?
|
Polymerase Chain Reaction | 2 | 2011 | 6069 | 0.020 |
Why?
|
11-beta-Hydroxysteroid Dehydrogenase Type 1 | 1 | 2011 | 29 | 0.020 |
Why?
|
Boston | 2 | 2015 | 9338 | 0.020 |
Why?
|
Oligodendroglioma | 1 | 2013 | 273 | 0.020 |
Why?
|
Anti-Inflammatory Agents | 1 | 2021 | 1808 | 0.020 |
Why?
|
Infant, Newborn | 3 | 2017 | 26346 | 0.020 |
Why?
|
Spirometry | 1 | 2014 | 929 | 0.020 |
Why?
|
Pediatrics | 1 | 2006 | 3606 | 0.020 |
Why?
|
Phosphatidylethanolamines | 1 | 2011 | 128 | 0.020 |
Why?
|
Selection Bias | 1 | 2012 | 361 | 0.020 |
Why?
|
Patient Selection | 1 | 2003 | 4255 | 0.020 |
Why?
|
DNA Transposable Elements | 1 | 2014 | 765 | 0.020 |
Why?
|
Neoplasms | 1 | 2019 | 22340 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2024 | 22332 | 0.020 |
Why?
|
Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2011 | 132 | 0.020 |
Why?
|
Disease Outbreaks | 1 | 2020 | 1759 | 0.020 |
Why?
|
Socioeconomic Factors | 3 | 2012 | 7838 | 0.020 |
Why?
|
Caspase 7 | 1 | 2010 | 51 | 0.020 |
Why?
|
Women's Health | 3 | 2005 | 2084 | 0.020 |
Why?
|
Chromosomes, Human, Pair 21 | 1 | 2010 | 228 | 0.020 |
Why?
|
Respiration | 1 | 2016 | 1653 | 0.020 |
Why?
|
Sexual Behavior | 2 | 2011 | 2193 | 0.020 |
Why?
|
Neural Stem Cells | 1 | 2017 | 898 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2023 | 3946 | 0.020 |
Why?
|
Caspase 9 | 1 | 2010 | 184 | 0.020 |
Why?
|
Spectrometry, X-Ray Emission | 1 | 2010 | 143 | 0.020 |
Why?
|
Cell Differentiation | 1 | 2007 | 11641 | 0.020 |
Why?
|
Filtration | 1 | 2010 | 224 | 0.020 |
Why?
|
Individuality | 1 | 2011 | 303 | 0.020 |
Why?
|
Phosphatidylcholines | 1 | 2011 | 403 | 0.020 |
Why?
|
Sex Distribution | 1 | 2014 | 2263 | 0.020 |
Why?
|
Limit of Detection | 1 | 2010 | 272 | 0.020 |
Why?
|
Heart Septal Defects | 1 | 2010 | 191 | 0.020 |
Why?
|
Epidemiologic Studies | 1 | 2012 | 677 | 0.020 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2017 | 1242 | 0.020 |
Why?
|
Secretory Leukocyte Peptidase Inhibitor | 1 | 2009 | 23 | 0.020 |
Why?
|
Pregnancy Trimester, Second | 1 | 2012 | 737 | 0.020 |
Why?
|
Oxidoreductases | 1 | 2011 | 409 | 0.020 |
Why?
|
Early Detection of Cancer | 1 | 2023 | 3236 | 0.020 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2016 | 1456 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2024 | 10429 | 0.020 |
Why?
|
Primary Health Care | 1 | 2005 | 4736 | 0.020 |
Why?
|
Trans-Activators | 1 | 2018 | 2850 | 0.020 |
Why?
|
Amino Acid Substitution | 1 | 2013 | 1740 | 0.020 |
Why?
|
Recurrence | 2 | 2013 | 8501 | 0.020 |
Why?
|
Erythrocytes | 1 | 2017 | 2395 | 0.020 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2009 | 323 | 0.020 |
Why?
|
HIV Infections | 4 | 2013 | 17533 | 0.020 |
Why?
|
Fas Ligand Protein | 1 | 2008 | 214 | 0.020 |
Why?
|
Insulin | 1 | 2022 | 6599 | 0.020 |
Why?
|
Norway | 1 | 2009 | 499 | 0.020 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 2009 | 386 | 0.020 |
Why?
|
Health Policy | 1 | 2020 | 2698 | 0.020 |
Why?
|
Thinness | 1 | 2011 | 482 | 0.020 |
Why?
|
Pregnancy Trimester, First | 1 | 2012 | 919 | 0.020 |
Why?
|
Factor Analysis, Statistical | 1 | 2010 | 999 | 0.020 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 2009 | 457 | 0.020 |
Why?
|
Genes, p16 | 1 | 2007 | 157 | 0.020 |
Why?
|
Interleukin-2 | 1 | 2014 | 1896 | 0.020 |
Why?
|
Urination Disorders | 1 | 2008 | 236 | 0.020 |
Why?
|
Reference Standards | 1 | 2010 | 1013 | 0.020 |
Why?
|
Sexual Partners | 1 | 2011 | 804 | 0.020 |
Why?
|
Substance-Related Disorders | 1 | 2003 | 4416 | 0.020 |
Why?
|
Nicotine | 1 | 2011 | 682 | 0.020 |
Why?
|
Quality of Life | 1 | 2008 | 13462 | 0.020 |
Why?
|
Mass Screening | 1 | 2022 | 5446 | 0.020 |
Why?
|
Time | 1 | 2008 | 550 | 0.020 |
Why?
|
Matrix Metalloproteinase 12 | 1 | 2005 | 45 | 0.020 |
Why?
|
Risk-Taking | 1 | 2011 | 1021 | 0.020 |
Why?
|
Creatinine | 1 | 2011 | 1915 | 0.020 |
Why?
|
Sexually Transmitted Diseases | 1 | 2011 | 667 | 0.020 |
Why?
|
Genes, Neoplasm | 1 | 2007 | 370 | 0.020 |
Why?
|
Hospitalization | 1 | 2005 | 10808 | 0.020 |
Why?
|
Spouses | 1 | 2008 | 288 | 0.020 |
Why?
|
Peak Expiratory Flow Rate | 1 | 2005 | 143 | 0.020 |
Why?
|
Tobacco Smoke Pollution | 1 | 2011 | 827 | 0.020 |
Why?
|
Cell Line, Tumor | 2 | 2015 | 17075 | 0.020 |
Why?
|
Body Weight | 2 | 2007 | 4622 | 0.020 |
Why?
|
Mice | 3 | 2024 | 81819 | 0.010 |
Why?
|
Genes, p53 | 1 | 2007 | 711 | 0.010 |
Why?
|
Infant | 2 | 2017 | 36386 | 0.010 |
Why?
|
Genes, ras | 1 | 2007 | 658 | 0.010 |
Why?
|
Cluster Analysis | 1 | 2011 | 2721 | 0.010 |
Why?
|
Body Weights and Measures | 1 | 2005 | 208 | 0.010 |
Why?
|
Mandelic Acids | 1 | 2004 | 46 | 0.010 |
Why?
|
Cadherins | 1 | 2009 | 900 | 0.010 |
Why?
|
Comorbidity | 2 | 2010 | 10563 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2021 | 4873 | 0.010 |
Why?
|
Protein Biosynthesis | 1 | 2011 | 2086 | 0.010 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2007 | 595 | 0.010 |
Why?
|
Waist-Hip Ratio | 1 | 2005 | 520 | 0.010 |
Why?
|
Intestinal Diseases | 1 | 2008 | 506 | 0.010 |
Why?
|
Fatty Acids | 1 | 2011 | 1806 | 0.010 |
Why?
|
Leptin | 1 | 2011 | 1596 | 0.010 |
Why?
|
Base Sequence | 1 | 2014 | 12403 | 0.010 |
Why?
|
Affect | 1 | 2010 | 1500 | 0.010 |
Why?
|
Endothelium, Vascular | 1 | 2015 | 4427 | 0.010 |
Why?
|
Zidovudine | 1 | 2004 | 626 | 0.010 |
Why?
|
Oxidative Stress | 1 | 2014 | 3141 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2014 | 4348 | 0.010 |
Why?
|
Anthropometry | 1 | 2007 | 1338 | 0.010 |
Why?
|
Hyperlipidemias | 1 | 2007 | 770 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2023 | 11868 | 0.010 |
Why?
|
Femur Neck | 1 | 2004 | 316 | 0.010 |
Why?
|
HIV Seronegativity | 1 | 2003 | 209 | 0.010 |
Why?
|
Critical Illness | 1 | 2015 | 2744 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2014 | 17594 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 3 | 2013 | 20659 | 0.010 |
Why?
|
Coronary Angiography | 1 | 2013 | 4493 | 0.010 |
Why?
|
Narcotics | 1 | 2003 | 332 | 0.010 |
Why?
|
Nuclear Family | 1 | 2002 | 311 | 0.010 |
Why?
|
Methadone | 1 | 2003 | 319 | 0.010 |
Why?
|
Brachytherapy | 1 | 2008 | 1222 | 0.010 |
Why?
|
Walking | 1 | 2007 | 1198 | 0.010 |
Why?
|
Attention | 1 | 2010 | 2419 | 0.010 |
Why?
|
Schizophrenia | 1 | 2019 | 6972 | 0.010 |
Why?
|
Anti-Asthmatic Agents | 1 | 2005 | 572 | 0.010 |
Why?
|
Prostatectomy | 1 | 2008 | 1782 | 0.010 |
Why?
|
Disorders of Excessive Somnolence | 1 | 2003 | 274 | 0.010 |
Why?
|
Animals | 3 | 2024 | 168764 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2013 | 11022 | 0.010 |
Why?
|
Premenopause | 1 | 2004 | 1037 | 0.010 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2008 | 3537 | 0.010 |
Why?
|
Androgen Antagonists | 1 | 2008 | 1411 | 0.010 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2009 | 2880 | 0.010 |
Why?
|
Chronic Disease | 1 | 2014 | 9347 | 0.010 |
Why?
|
Treatment Outcome | 4 | 2008 | 65188 | 0.010 |
Why?
|
Substance Abuse, Intravenous | 1 | 2003 | 531 | 0.010 |
Why?
|
Environment | 1 | 2004 | 1114 | 0.010 |
Why?
|
Prostate-Specific Antigen | 1 | 2008 | 2464 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2019 | 26318 | 0.010 |
Why?
|
Neovascularization, Pathologic | 1 | 2008 | 2631 | 0.010 |
Why?
|
Survivors | 1 | 2008 | 2372 | 0.010 |
Why?
|
Databases, Factual | 1 | 2013 | 8067 | 0.010 |
Why?
|
Urban Population | 1 | 2005 | 2040 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2007 | 4893 | 0.010 |
Why?
|
Social Support | 1 | 2006 | 2192 | 0.010 |
Why?
|
Data Collection | 1 | 2005 | 3318 | 0.010 |
Why?
|
ROC Curve | 1 | 2003 | 3620 | 0.010 |
Why?
|
Uterine Neoplasms | 1 | 2004 | 1421 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2013 | 9373 | 0.010 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2003 | 1899 | 0.010 |
Why?
|
Lumbar Vertebrae | 1 | 2004 | 1873 | 0.010 |
Why?
|
Mental Health | 1 | 2007 | 3278 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2005 | 3564 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2009 | 15398 | 0.010 |
Why?
|
Myocardial Infarction | 1 | 2013 | 11499 | 0.010 |
Why?
|
Medicaid | 1 | 2005 | 2833 | 0.010 |
Why?
|
Registries | 1 | 2005 | 8297 | 0.000 |
Why?
|
Anti-HIV Agents | 1 | 2004 | 4559 | 0.000 |
Why?
|
Disease Models, Animal | 1 | 2007 | 18293 | 0.000 |
Why?
|
Hypertension | 1 | 2007 | 8626 | 0.000 |
Why?
|
Ovarian Neoplasms | 1 | 2004 | 4900 | 0.000 |
Why?
|
Electroencephalography | 1 | 2002 | 6273 | 0.000 |
Why?
|
Postoperative Complications | 1 | 2008 | 15747 | 0.000 |
Why?
|